
Carlipride-MV1 Tablet SR
Marketer
Carmentis Health Care
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Carlipride-MV1 Tablet SR
Diabetol-CX Combination Tablets are anti-diabetic medications used to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Diabetol-CX should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is vital, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels and potentially severe complications, including kidney damage, vision impairment, neuropathy, and limb loss. Diabetol-CX is one component of a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are crucial for prevention. Alcohol consumption should be minimized due to its hypoglycemic risk. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before use. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Uses of Carlipride-MV1 Tablet SR
Managing Type 2 diabetes
Major Benefits of Carlipride-MV1 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Carlipride-MV1 Tablet SR whole; do not chew, crush, or divide the tablet. Administer this medication on an empty stomach.
Common Side effects of Carlipride-MV1 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Carlipride-MV1 Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Carlipride-MV1 Tablet SR on an empty stomach.
How Carlipride-MV1 Tablet SR works:
Carlipride-MV1 sustained-release tablets contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Carlipride-MV1 Tablet SR poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Carlipride-MV1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Carlipride-MV1 tablet likely poses a risk to breastfeeding infants. Available human data indicate potential drug transfer into breast milk, with the possibility of infant harm.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of Carlipride-MV1 Tablet SR is inadvisable for individuals with impaired kidney function and should be avoided. Patients with severe kidney disease are strongly discouraged from using Carlipride-MV1 Tablet SR. Medical advice is recommended.
LiverCAUTION
Patients with liver impairment should use Carlipride-MV1 Tablet SR cautiously, potentially requiring dose modification. Consult your physician. A reduced initial dose is typically advised for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.
What if you forget to take Carlipride-MV1 Tablet SR :
Should you forget a Carlipride-MV1 Tablet SR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Carlipride-MV1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
